Hantz Financial Services’s iShares Biotechnology ETF IBB Stock Holding History

Hantz Financial Services’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2K	Sell	10 -71	-88%	-$12.1K	﹤0.01%	2289
2025 Q4	$14K	Buy	81 +31	+62%	+$5.04K	﹤0.01%	1904
2025 Q3	$7K	Buy	+50	New	+$6.83K	﹤0.01%	1933
2025 Q1	–	Sell	-30	Closed	-$4K	–	1826
2024 Q4	$4K	Hold	30	–	–	﹤0.01%	920
2024 Q3	$4K	Hold	30	–	–	﹤0.01%	897
2024 Q2	$4K	Hold	30	–	–	﹤0.01%	883
2024 Q1	$4K	Hold	30	–	–	﹤0.01%	970
2023 Q4	$4K	Hold	30	–	–	﹤0.01%	944
2023 Q3	$4K	Hold	30	–	–	﹤0.01%	940
2023 Q2	$4K	Hold	30	–	–	﹤0.01%	919
2023 Q1	$4K	Hold	30	–	–	﹤0.01%	925
2022 Q4	$4K	Hold	30	–	–	﹤0.01%	894
2022 Q3	$4K	Hold	30	–	–	﹤0.01%	878
2022 Q2	$4K	Buy	+30	New	+$3.56K	﹤0.01%	879

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Hantz Financial Services's IBB Position: Q1 2026 in Review

Hantz Financial Services reduced its iShares Biotechnology ETF (IBB) stake by 88% in Q1 2026, selling an estimated $12.1K and leaving 10 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #2289.

Hantz Financial Services first reported a position in IBB in Q2 2022 and has held it in 14 quarters since. The position peaked at $14K in Q4 2025. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Hantz Financial Services held 10 shares of iShares Biotechnology ETF worth $2K as of Q1 2026.
Hantz Financial Services sold 71 iShares Biotechnology ETF shares in Q1 2026, an estimated $12.1K.
iShares Biotechnology ETF made up ﹤0.01% of Hantz Financial Services's portfolio in Q1 2026, its #2289 holding.
Hantz Financial Services first reported a position in iShares Biotechnology ETF in Q2 2022 and has held it in 14 quarters since.
Hantz Financial Services's iShares Biotechnology ETF position peaked at $14K in Q4 2025.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Hantz Financial Services's 13F filing for Q1 2026, filed 1 May 2026.